http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105055308-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28908f42a3efe1ea914a0ca680268028 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 |
| filingDate | 2015-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11a5e63913a29e394e6c79e84e7cb22e |
| publicationDate | 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105055308-A |
| titleOfInvention | Platinum-based antitumor drug oxaliplatin composition liquid injection |
| abstract | The invention discloses a platinum-based antitumor drug oxaliplatin composition liquid injection, and belongs to the technical field of medicines. The composition is prepared from oxaliplatin and calcium chloride, wherein oxaliplatin is a crystal, and is as shown in a diagram I which is an X-ray powdered diffraction diagram measured by using a Cu-K alpha ray. Different from the crystal form structure in the prior art, tests verify that the new crystal form of oxaliplatin has the advantages of high purity, good fluidity, good stability, low impurity content and hard moisture absorption, is safe and reliable in clinical application. The liquid injection prepared from the new crystal form compound is simple in ingredient and high in stability. |
| priorityDate | 2015-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.